Results 171 to 180 of about 3,947 (298)

Circulating miR-223-3p as an Independent Biomarker of Recurrent Thrombotic Risk After Ischemic Stroke. [PDF]

Biomedicines
Balczó B, Maricza K, Molnár K, Elek Z, Bánlaki Z, Kovács-Nagy R, Keszler G, Rónai Z, Molnár A, Molnár T.   +9 more
europepmc   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

Photographic recording of the ESR [PDF]

Journal of Clinical Pathology, 1982
openaire   +2 more sources

Proteomic signatures of intermittent pneumatic compression in patients with large artery atherosclerotic stroke. [PDF]

iScience
Lei S, Wang Z, Ouyang D, Huang T, Huang K, Li X, Huang ZX.   +6 more
europepmc   +1 more source

From Interferon Signature to the Clinical Landscape: Type I Interferonopathies

Arthritis &Rheumatology, Accepted Article.
Background Type I interferonopathies are heterogeneous diseases driven by dysregulated IFN‐I signaling. Diagnosis is challenging due to clinical/molecular variability and the need for IFN‐I quantification. Objective To characterize the clinical, immunological, genetic, molecular profiles of patients with suspected enhanced IFN‐I signaling, and assess ...
Ismail Yaz, Seza Ozen, Hacer N. Bildik, Canberk Ipsir, Dilara Unal, Saliha Esenboga, Begum Cicek, Mehmet E. Seker, Fatima Aerts‐Kaya, Seher Sener, Mehmet O. Erkan, Hanife Avci, Deniz Cagdas, Ilhan Tezcan   +13 more
wiley   +1 more source

Planning to fail? Credibility and financing of corporate transition plans in hard-to-abate sectors. [PDF]

iScience
Klein SMA, Polzin F, Urbach X.
europepmc   +1 more source

Scientific collaboration in data‐intensive research networks: PhD fellows' expectations and early experiences

Journal of the Association for Information Science and Technology, EarlyView.
Abstract Collaboration has become important at all stages of research careers. In data‐intensive research fields such as wind energy, many PhD fellows are socialized to such collaboration in networks that train a cohort of PhD fellows. Based on interviews with 23 PhD fellows in four wind‐energy training networks, we investigate their expectations and ...
Grischa Fraumann, Haakon Lund, Frans van der Sluis, Morten Hertzum   +3 more
wiley   +1 more source

AI-based radiomic features predict outcomes and the added benefit of chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A multi-institutional study. [PDF]

Cancer Lett
Khorrami M, Mutha P, Barrera C, Viswanathan VS, Ardeshir-Larijani F, Jain P, Higgins K, Madabhushi A.   +7 more
europepmc   +1 more source

One‐Step Electrodeposition of Iron Oxyhydroxide Onto 3D Porous Graphene Substrates for on Chip Asymmetric Micro‐Supercapacitors

Batteries &Supercaps, Volume 8, Issue 3, March 2025.
A micro‐supercapacitor with electrodeposited iron oxyhydroxide (FeOOH) as the negative electrode and birnessite manganese oxide (MnO2) as the positive electrode achieves a 2 V working voltage, stable cycling in an aqueous electrolyte, and high energy and power densities of 21 μWh cm‐2 and 2.5 mW cm‐2 respectively.
Filipe Braga, Gabriel Casano, Manel Sonni, Harry Finch, Vinod R. Dhanak, Marco Caffio, Laurence J. Hardwick   +6 more
wiley   +1 more source

Prevalence and associated factors of antipsychotic-induced extrapyramidal symptoms in the Tigray region. [PDF]

BMC Psychiatry
Gebremariam EH, Begashaw TD, Tsegay L, Kindeya GG, Weldemariam AG, Gebru WA, Kahsay HD, Tsegabrhan H.   +7 more
europepmc   +1 more source